A5010959229- Substance Abuse Treatment and Outcomes
- Opioid Use Disorder Treatment
- Homelessness and Social Issues
- Pain Management and Opioid Use
- Prenatal Substance Exposure Effects
- Pharmaceutical Practices and Patient Outcomes
- Mental Health Treatment and Access
- HIV, Drug Use, Sexual Risk
- Health disparities and outcomes
- Alcohol Consumption and Health Effects
- Urban, Neighborhood, and Segregation Studies
- Food Security and Health in Diverse Populations
- Child Abuse and Trauma
- Child and Adolescent Health
- Poisoning and overdose treatments
- Dental Health and Care Utilization
- Cannabis and Cannabinoid Research
- Schizophrenia research and treatment
- Oral Health Pathology and Treatment
- Sport Psychology and Performance
- Ethics and Legal Issues in Pediatric Healthcare
- COVID-19 Impact on Reproduction
- Interpreting and Communication in Healthcare
- Youth Substance Use and School Attendance
- Evaluation and Performance Assessment
Duke University
2024
Indiana University – Purdue University Indianapolis
2014-2023
Richard M. Fairbanks Foundation
2022
Otsuka (United States)
2018
Article Abstract Objective: An epidemic of prescription drug abuse is disproportionately impacting the mentally ill. We examined utility a state monitoring database for assessing recent controlled substance prescribing to patients presenting dual diagnosis treatment. Method: In community mental health center that provides integrated care, we queried Indiana Scheduled Prescription Electronic Collection and Tracking (INSPECT) system all cases were open as August 2, 2011, had been...
Abstract Background and Objectives More than nine million U.S. adults have a co‐occurring mental health substance use disorder. The self‐medication hypothesis suggests that individuals with unmet need may alleviate the symptoms of their illness by using alcohol or drugs. We examine relationship between subsequent among history depression as well differences in metro nonmetro areas. Methods used repeated cross‐sectional data from National Survey on Drug Use Health (NSDUH), 2015–2018 after...
Of 12 consecutive patients with bipolar mood disorders satisfying DSM-III criteria, six were discovered to have five or more psychomotor epileptic symptoms. All of the had olfactory hallucinations, metamorphopsias, and multiple déjà vu mystical experiences. Each them responded lithium carbonate a first-degree relative disorder. The authors suggest that symptoms may be prevalent in than has hitherto been recognized.
Background and Objectives Fourfold increases in opioid prescribing dispensations over 2 decades the U.S. has paralleled addictions overdoses, requiring new preventative, diagnostic, treatment strategies. This study examines Prescription Drug Monitoring Program (PDMP) tracking as a novel measure of addiction outcomes university-affiliated integrated mental health-addiction clinic. Methods Repeated parametrics examined PDMP urine drug screening (UDS) data before after first injection for all...
Chronic liver diseases (CLDs) and substance use disorders (SUDs) are increasingly prevalent often coexist. Contemporary studies describing the characteristics hospitalization trends of those with comorbid CLD-SUD lacking. We aimed to characterize a population-based cohort describe in these hospitalizations over time by individual-level characteristics.We performed cross-sectional analysis National Inpatient Sample from 2005 through 2017. Diagnosis codes were used identify adult CLD, SUD, or...
Prescription Drug Monitoring Programs (PDMPs) can serve as screening tools and support the clinical decision-making process in patients receiving opioids. The objective of study was to utilize 2014 INSPECT (Indiana's PDMP) data identify factors that increase patients' likelihood engage opioid-related risk behaviors.Based on a literature review, four behaviors were identified: Receiving >90 morphine milligram equivalents (MME), having >4 opioid prescribers, obtaining opioids from pharmacies,...